Arnold von Eckardstein

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Florian Kronenberg, Samia Mora, Erik S.G. Stroes et al. · European Heart Journal · 2022 · 1.3K citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

Børge G. Nordestgaard, Anne Langsted, Samia Mora et al. · European Heart Journal · 2016 · 835 citations · Full text

Life Sciences, Nutritional Sciences, Clinical Nutrition +13

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction

Lorenz Räber, Yasushi Ueki, Tatsuhiko Otsuka et al. · JAMA · 2022 · 589 citations · Full text

Medicine, Cardiology, Pharmacology +17

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

Christian Besler, Kathrin Heinrich, Lucia Rohrer et al. · Journal of Clinical Investigation · 2011 · 530 citations

Medicine, Cardiology, Pharmacology +16

Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men

Gerd Assmann, H. Schulte, Arnold von Eckardstein · The American Journal of Cardiology · 1996 · 454 citations

Medicine, Biochemistry, Cardiology +13